Effects of a selective glucocorticoid receptor modulator (AZD9567) versus prednisolone in healthy volunteers: two phase 1, single-blind, randomised controlled trials
Hegelund Myrbäck, Tove, Prothon, Susanne, Edman, Karl, Leander, Jacob, Hashemi, Mahdi, Dearman, Matthew, Edenro, Goran, Svanberg, Petter, Andersson, Eva-Marie, Almquist, Joachim, Ämmälä, Carina, Hendrickx, Ramon, Taib, Ziad, Johansson, Kicki A, Berggren, Anders R, Keen, Christina M, Eriksson, Ulf G, Fuhr, Rainard, Carlsson, Björn C L
Published in The Lancet. Rheumatology (01.01.2020)
Published in The Lancet. Rheumatology (01.01.2020)
Get more information
Journal Article
Efficacy and safety of a CXCR2 antagonist, AZD5069, in patients with uncontrolled persistent asthma: a randomised, double-blind, placebo-controlled trial
O'Byrne, Paul M, Metev, Hristo, Puu, Margareta, Richter, Kai, Keen, Christina, Uddin, Mohib, Larsson, Bengt, Cullberg, Marie, Nair, Parameswaran
Published in The lancet respiratory medicine (01.10.2016)
Published in The lancet respiratory medicine (01.10.2016)
Get more information
Journal Article